Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis.
Valdemar Wendelboe NielsenTamara Theresia LundRobert GniadeckiRasmus Huan OlsenChristoffer Valdemar NissenJakob Ferløv Baselius SchwensenSimon Francis ThomsenPublished in: Dermatologic therapy (2020)